Drug Discovery

Generative AI May Accelerate Drug Discovery for COVID Antivirals

June 29, 2023 - Researchers have developed a generative artificial intelligence (AI) model capable of designing novel molecules to block SARS-CoV-2, the virus that causes COVID-19, according to a study published in Science Advances last week. Drug discovery is often a long, challenging process, the researchers noted, particularly when the structure of drug-target...

Read More


More Articles

Generative Artificial Intelligence Tool May Support Drug Development

by Shania Kennedy

Researchers have developed a generative artificial intelligence (AI)-based framework known as G2Retro to automatically generate chemical reactions for given molecules, which could accelerate the drug...

Google Cloud Launches AI Solutions for Drug Discovery, Precision Medicine

by Shania Kennedy

Google Cloud announced the launch of two new artificial intelligence (AI)-based life sciences solutions to accelerate drug discovery and precision medicine for pharmaceutical firms, biotech companies,...

Moderna, IBM Strike Quantum Computing Partnership to Advance mRNA Research

by Shania Kennedy

Moderna and IBM announced a partnership to leverage novel technologies, such as artificial intelligence (AI) and quantum computing, to accelerate messenger RNA (mRNA) research.  Quantum computing...

Cleveland Clinic, IBM Partner to Install First Healthcare Quantum Computer

by Shania Kennedy

Cleveland Clinic and IBM announced that the deployment of the first healthcare quantum computer in the US has begun on the health system’s main campus, a key component of the two...

Precision Medicine Test Predicts Patient Response to Treatment

by Erin McNemar, MPA

A new study indicated that a precision medicine test using blood proteins can identify patients with idiopathic multicentric Castleman disease (iMCD) and are most likely to respond to treatment. The...

Developing Precision Medicine for Chronic Kidney Disease

by Erin McNemar, MPA

In a genome-wide association study, Perelman School of Medicine at the University of Pennsylvania researchers identified 182 genes potentially linked to kidney function and 88 genes for hypertension....

Genetic Risk Factors IDed for Depression Can Boost Drug Therapies

by Jill McKeon

Using genomic data, researchers identified genetic risk factors for depression, according to a study published in Nature Neuroscience. The results show potential for identifying new drug therapies and...

Clinical Trial Uses Precision Medicine for Pancreatic Cancer Drugs

by Jessica Kent

The Pancreatic Cancer Action Network (PanCAN) has launched Precision Promise, a precision medicine clinical trial that will aim to improve pancreatic cancer drugs. Moores Cancer Center at UC San Diego...

Genomic Data Analysis Uncovers 13 New Alzheimer’s Genes

by Jessica Kent

A first-of-its-kind genomic data analysis revealed 13 new genetic variants associated with Alzheimer’s disease, according to a study conducted by researchers from Massachusetts General Hospital...

$1M Award Will Help Expand COVID-19 Treatment Database

by Jessica Kent

Researchers at the Center for Cytokine Storm Treatment and Laboratory at the Perelman School of Medicine at the University of Pennsylvania have received a $1 million award to enhance their COVID-19...

Machine Learning Technique Could Accelerate Drug Discovery

by Jessica Kent

A machine learning technique can quickly estimate the binding affinities between drug candidates and their targets, potentially accelerating drug discovery and protein engineering, a study published in...

Initiative to Boost Minority Representation in Genetics Research

by Jessica Kent

Henry Ford Cancer Institute is launching a new, community-based initiative to significantly improve minority representation in cancer genetics research and clinical trials. Supported by a $750,000...

Machine Learning Identifies Existing Drugs to Treat COVID-19

by Jessica Kent

Machine learning could help detect existing drugs that could help fight COVID-19, particularly in elderly populations, a study published in Nature Communications revealed. One of the many major...

Precision Medicine Platform Aims to Advance Cancer Gene Therapies

by Jessica Kent

A team from Cleveland Clinic has developed a precision medicine platform designed to accelerate cancer gene therapies and genome-informed drug discovery. In a study published in Nature Genetics,...

New Tool Could Advance Precision Medicine for Incurable Diseases

by Jessica Kent

A new tool that focuses on RNA could accelerate the development of precision medicine treatments for incurable diseases, including a type of metastatic breast cancer, according to a study published in...

Gene Expression Database May Help Curb Antibiotic Resistance

by Jessica Kent

A gene expression database analyzed different strains of the bacteria that causes pneumonia, meningitis, and middle ear infections, which could lead to new treatments for these conditions and curb...

Collecting Genomic Data to Accelerate COVID-19 Drug Discovery

by Jessica Kent

In the race to find potential treatments and therapies for COVID-19, genomic data is being generated with unprecedented frequency. For more coronavirus updates, visit our resource page, updated...

Big Data Analytics Tool Could Help Guide Cancer Precision Medicine

by Jessica Kent

A big data analytics tool that uses information from multiple cancer types could help researchers identify potential treatments and accelerate precision medicine, a study published in the Journal of...

Genomic Data Collaboration to Aid Precision Medicine, Drug Discovery

by Jessica Kent

The Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus is partnering with the Regeneron Genetics Center (RGC) to advance precision medicine and drug...

Recent Articles

Upcoming Webcasts